Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
01/1999
01/05/1999US5856084 Recombinant dna molecules which code for polypeptides having specificity towards a hepatitis b viral antigen.
01/05/1999US5855891 Ichimeric papillomavirus-like particles
01/05/1999US5855867 Radiological imaging
01/05/1999CA2046956C O-methyl derivatives of azithromycin a, process and intermediate for their preparation, and use thereof in the preparation of pharmaceuticals
01/03/1999CA2236462A1 Murc
01/02/1999CA2221861A1 Ynl075w/htxft19
01/01/1999CA2236459A1 Novel compounds
01/01/1999CA2236452A1 Gida1
01/01/1999CA2236441A1 Gida2
01/01/1999CA2236435A1 Gida2
01/01/1999CA2236431A1 Gidb
01/01/1999CA2236425A1 Gida1
01/01/1999CA2235785A1 Serine/threonine protein kinase (h-sgk2)
12/1998
12/30/1998WO1998059063A2 Bovine adenovirus type 3 genome
12/30/1998WO1998058933A1 Cephalosporin compounds, use thereof and intermediate compounds of the same
12/30/1998WO1998058931A1 PROCESS FOR PRODUCING β-LACTAM DERIVATIVES
12/30/1998WO1998058928A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
12/30/1998WO1998058677A1 Pharmaceutical formulations containing voriconazole
12/30/1998WO1998058675A1 Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent
12/30/1998WO1998058670A1 Methods of immunizing adults using anti-meningococcal vaccine compositions
12/30/1998WO1998058668A2 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae
12/30/1998WO1998058663A1 Use of proteolytic enzymes for influencing cytokines
12/30/1998WO1998044944A3 Stabilized human papillomavirus formulations
12/30/1998WO1998043670A3 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a
12/30/1998EP0887416A2 Human AFC1
12/30/1998EP0887415A2 Human RCE1
12/30/1998EP0887413A2 Histidine kinase
12/30/1998EP0887411A2 N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Streptococcus pneumoniae
12/30/1998EP0887410A2 DNA encoding a plasminogen activating protein
12/30/1998EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor
12/30/1998EP0887406A2 A member of the FRZB family, franzzled
12/30/1998EP0887352A1 Carbapenem derivatives and antimicrobials
12/30/1998EP0886677A1 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound
12/30/1998EP0886651A1 Persephin and related growth factors
12/30/1998EP0886646A1 Novel compounds
12/30/1998EP0886635A1 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity
12/30/1998EP0886520A1 Caffeine and clemastine for treating respiratory disorders
12/30/1998EP0766688A4 Synthesis of oligonucleotides
12/30/1998EP0760661B1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
12/30/1998EP0661999B1 Anti-feline immunodeficiency virus (fiv) vaccines
12/30/1998EP0591384B1 Attenuated revertant serotype 1 marek's disease vaccine
12/30/1998EP0539522B1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease
12/30/1998EP0522084B1 Antiviral compositions and method for their use
12/30/1998CN1203630A 治疗和诊断组合物 Therapeutic and diagnostic compositions
12/30/1998CN1203600A Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
12/30/1998CN1203596A Furan-and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of replication of HIV-1 and HIV-1 mutants
12/30/1998CN1203590A Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/30/1998CN1203530A Treatment of CNS effect of HIV with VX-475, alone or in combination with AZT or 3TC
12/30/1998CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor
12/30/1998CN1203528A Use of gamma-RAR-specific agonist ligand to increase apoptosis rate
12/30/1998CN1203275A Processes for preparation of Marek's disease virus using continuous mammalian cell lines
12/30/1998CN1203232A 2-carboxymethyl-5-(5-fluoro cyti midine-1-yl) 1,3-oxythiapentane and its derivatives
12/30/1998CN1203224A Process for preparation of (1S,2R)-1-amino-2-indanol-(R,R)-tartrate methanol solvate
12/30/1998CA2594375A1 Bovine adenovirus type 3 genome
12/30/1998CA2294453A1 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
12/30/1998CA2294348A1 Vaccines containing bordetella pertussis antigen
12/30/1998CA2294283A1 Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent
12/29/1998US5854416 Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
12/29/1998US5854289 Guanylhydrazones and their use to treat inflammatory conditions
12/29/1998US5854280 Antifungal sordaridin derivatives
12/29/1998US5854242 Benzoxazine antimicrobial agents
12/29/1998US5854234 Amidino dervatives useful as nitric oxide synthase inhibitors
12/29/1998US5854219 9-N-ethenyl derivatives of 9(S)-erythromycylamine
12/29/1998US5854213 Antifungal cyclohexapeptides
12/29/1998US5854055 Recombinant mycobacteria
12/29/1998US5854038 Localization of a therapeutic agent in a cell in vitro
12/29/1998US5854020 TCSTS polynucleotides
12/29/1998US5854007 Process for producing GM1 specific antibodies
12/29/1998US5853987 Decorin binding protein compositions and methods of use
12/29/1998US5853732 Pharmaceutical compositions containing kukui nut oil
12/29/1998US5853725 Prevention and treatment of retroviral disease
12/29/1998US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
12/29/1998US5853003 Treatment and diagnosis of respiratory disorders using fluorocarbon liquids
12/29/1998CA2152817C Novel pyridone carboxylic acid derivatives
12/29/1998CA2129554C Recombinant antibodies specific for tnf-.alpha.
12/29/1998CA2064029C Use of mycobacterium vaccae in the prevention of aids
12/29/1998CA1340297C Conjugation of polymer to colony stimulating factor-1
12/26/1998CA2235778A1 Novel glmu
12/24/1998DE19726255A1 Beeinflussung von Cytokinen durch proteolytische Enzyme Influence of cytokines by proteolytic enzymes
12/24/1998DE19722846A1 Leukotrien-B¶4¶-Derivate, insbesondere 7-Methylcyclohexyl-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular 7-methylcyclohexyl-LTB¶4¶ antagonists
12/24/1998CA2234418A1 Human afc1
12/24/1998CA2234402A1 Human rce1
12/23/1998WO1998057994A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
12/23/1998WO1998057976A1 Secreted proteins and polynucleotides encoding them
12/23/1998WO1998057967A1 An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same
12/23/1998WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/23/1998WO1998057931A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto
12/23/1998WO1998057660A1 Adjuvant compositions for vaccines
12/23/1998WO1998057659A1 Adjuvant compositions for vaccines
12/23/1998WO1998057657A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
12/23/1998WO1998057637A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
12/23/1998WO1998057555A1 Fermentation products and method for preventing food poisoning
12/23/1998WO1998042868A3 Screening method for proline-rich proteins
12/23/1998EP0885966A2 Novel compouds
12/23/1998EP0885965A2 Histidine kinase polypeptides
12/23/1998EP0885963A2 Compounds comprising polypeptides and polynucleotides of Streptococcus pneumoniae,said polypeptides being related by amino acid sequence homology to SapR from Streptococcus mutans polypeptide
12/23/1998EP0885960A2 G-protein coupled receptor (H7TBA62)
12/23/1998EP0885903A2 Nucleic acid encoding streptococcus pheumoniae response regulator
12/23/1998EP0885902A2 Nucleic acid encoding Streptococcus pneumoniae response regulator